These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 15990699)

  • 21. Antagonism of transforming growth factor-Beta signaling inhibits fibrosis-related genes.
    Liu XJ; Ruan CM; Gong XF; Li XZ; Wang HL; Wang MW; Yin JQ
    Biotechnol Lett; 2005 Oct; 27(20):1609-15. PubMed ID: 16245182
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeted disruption of Smad4 in cardiomyocytes results in cardiac hypertrophy and heart failure.
    Wang J; Xu N; Feng X; Hou N; Zhang J; Cheng X; Chen Y; Zhang Y; Yang X
    Circ Res; 2005 Oct; 97(8):821-8. PubMed ID: 16151019
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapeutic strategies against TGF-beta signaling pathway in hepatic fibrosis.
    Liu X; Hu H; Yin JQ
    Liver Int; 2006 Feb; 26(1):8-22. PubMed ID: 16420505
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transforming growth factor-beta/connective tissue growth factor axis in the kidney.
    Qi W; Chen X; Poronnik P; Pollock CA
    Int J Biochem Cell Biol; 2008; 40(1):9-13. PubMed ID: 17300978
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transforming growth factor-beta signaling through the Smad proteins: role in systemic sclerosis.
    Verrecchia F; Mauviel A; Farge D
    Autoimmun Rev; 2006 Oct; 5(8):563-9. PubMed ID: 17027893
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantitative analysis of growth factor production in the mechanism of fibrosis in agnogenic myeloid metaplasia.
    Wang JC; Chang TH; Goldberg A; Novetsky AD; Lichter S; Lipton J
    Exp Hematol; 2006 Dec; 34(12):1617-23. PubMed ID: 17157157
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transforming growth factor beta-1 signalling in canine hepatic diseases: new models for human fibrotic liver pathologies.
    Spee B; Arends B; van den Ingh TS; Brinkhof B; Nederbragt H; Ijzer J; Roskams T; Penning LC; Rothuizen J
    Liver Int; 2006 Aug; 26(6):716-25. PubMed ID: 16842329
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rapid closure of midgestational excisional wounds in a fetal mouse model is associated with altered transforming growth factor-beta isoform and receptor expression.
    Goldberg SR; McKinstry RP; Sykes V; Lanning DA
    J Pediatr Surg; 2007 Jun; 42(6):966-71; discussion 971-3. PubMed ID: 17560204
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IL-13 signaling via IL-13R alpha2 induces major downstream fibrogenic factors mediating fibrosis in chronic TNBS colitis.
    Fichtner-Feigl S; Young CA; Kitani A; Geissler EK; Schlitt HJ; Strober W
    Gastroenterology; 2008 Dec; 135(6):2003-13, 2013.e1-7. PubMed ID: 18938165
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of ALK5 as a new approach to treat liver fibrotic diseases.
    de Gouville AC; Huet S
    Drug News Perspect; 2006 Mar; 19(2):85-90. PubMed ID: 16628263
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Atrial natriuretic peptide inhibits transforming growth factor beta-induced Smad signaling and myofibroblast transformation in mouse cardiac fibroblasts.
    Li P; Wang D; Lucas J; Oparil S; Xing D; Cao X; Novak L; Renfrow MB; Chen YF
    Circ Res; 2008 Feb; 102(2):185-92. PubMed ID: 17991884
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Deletion of protein kinase C-beta isoform in vivo reduces renal hypertrophy but not albuminuria in the streptozotocin-induced diabetic mouse model.
    Meier M; Park JK; Overheu D; Kirsch T; Lindschau C; Gueler F; Leitges M; Menne J; Haller H
    Diabetes; 2007 Feb; 56(2):346-54. PubMed ID: 17259378
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Decorin-mediated transforming growth factor-beta inhibition ameliorates adverse cardiac remodeling.
    Jahanyar J; Joyce DL; Southard RE; Loebe M; Noon GP; Koerner MM; Torre-Amione G; Youker KA
    J Heart Lung Transplant; 2007 Jan; 26(1):34-40. PubMed ID: 17234515
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Structure and function of transforming growth factor-beta].
    Miyazono K
    Tanpakushitsu Kakusan Koso; 1991 May; 36(7):1350-6. PubMed ID: 1651541
    [No Abstract]   [Full Text] [Related]  

  • 35. [Detection of serum transforming growth factor beta 1 in diagnosis of hepatic fibrosis in schistosomiasis and evaluation of treatment efficacy].
    Yan SN; Fang H; Xiang LK
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2003; 21(3):189-90. PubMed ID: 14628358
    [No Abstract]   [Full Text] [Related]  

  • 36. Pulmonary fibrosis: a cellular overreaction or a failure of communication?
    Sheppard D
    J Clin Invest; 2001 Jun; 107(12):1501-2. PubMed ID: 11413155
    [No Abstract]   [Full Text] [Related]  

  • 37. Transforming growth factor beta in tissue fibrosis.
    Border WA; Noble NA
    N Engl J Med; 1994 Nov; 331(19):1286-92. PubMed ID: 7935686
    [No Abstract]   [Full Text] [Related]  

  • 38. Opportunities for the discovery of novel therapies for fibrotic diseases.
    Franklin TJ
    Exp Nephrol; 1995; 3(2):143-7. PubMed ID: 7773637
    [No Abstract]   [Full Text] [Related]  

  • 39. Transforming growth factor beta signaling, vascular remodeling, and hypertension.
    August P; Suthanthiran M
    N Engl J Med; 2006 Jun; 354(25):2721-3. PubMed ID: 16790709
    [No Abstract]   [Full Text] [Related]  

  • 40. [Relationship of transforming growth factor beta and gene polymorphism to fibrosis].
    Li J; Fan XY
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2004 Oct; 22(5):382-4. PubMed ID: 15555319
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.